HOME >> BIOLOGY >> NEWS
Scientists identify genetic pathways essential to RNA interference

A research team based at Massachusetts General Hospital (MGH) has identified 80 new genes essential to the process of RNA interference (RNAi), a powerful new research tool for inactivating genes in plants or animals. They used the RNAi process itself to find new genes that participate in the gene-silencing mechanism, which someday may help to fight human disease. The report will appear in the journal Science and is receiving early online release on the Science Express website at http://www.sciencexpress.org.

"The gene activation produced by RNAi is exquisitely specific, which gives it enormous potential for therapeutic application," says Gary Ruvkun, PhD, of the MGH Department of Molecular Biology, the study's senior author. "Imagine short, double-stranded RNA molecules that could be synthesized quickly and inexpensively to silence a single gene. Promising targets could include viruses like HIV and hepatitis C or cancer-causing oncogenes. An RNAi-based treatment for age-related macular degeneration is already in clinical trials." Ruvkun is a professor of Genetics at Harvard Medical School.

RNAi was originally identified in the C. elegans roundworm and the flowering plant Arabidopsis thaliana, both of which are common model organisms for biological research. The process interrupts the usual transfer of instructions from double-stranded DNA, through single-stranded messenger RNA and finally into proteins. Short, double-stranded pieces of RNA bind to the complementary messenger RNA segments, shutting down gene expression. RNAi occurs naturally in plants and animals and may help control resistance to viral infection, among other functions.

For the current study, lead author John Kim, PhD, and his colleagues developed a strain of C. elegans into which they added a gene that caused the worms to glow under ultraviolet light but also turned that gene off using RNAi. They then used RNAi to inacti
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
24-Mar-2005


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2020)... ... February 05, 2020 , ... ... greater ease, efficiency and insight to sample processing within laboratories. , Built ... laboratories conducting research in various fields, LabKey Sample Manager has been designed with ...
(Date:1/29/2020)... ... January 29, 2020 , ... ... new Analytics and Data Sciences practice, providing consulting services for strategy, research and ... announced by Mike Townley, co-founder and Managing Partner of CREO, an innovative management ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... companies and government agencies, announced that the firm has established a presence in ... Cambridge office will be in the Cambridge Innovation Center (CIC), at One Broadway ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... Pa. (PRWEB) , ... February 19, 2020 , ... ... and process solutions for the life sciences industry, today announced the opening of ... Kenji Nagamura, Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... in North America, today announced that the City of Fort Worth has partnered ... management needs. Commencing in April of 2020, Synagro will assume operation of the ...
(Date:2/5/2020)... BEACH, Fla. (PRWEB) , ... February 05, 2020 , ... ... an annual observance, sponsored by The National Organization for Rare Disorders (NORD), to raise ... patients’ lives ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” rare ...
(Date:1/28/2020)... ... 28, 2020 , ... Lifecycle Biotechnologies announced today ... manufactures within North America. Both Lifecycle and Midland have supported this industry for ... to pool their collective resources and provide the industry with support, service, and ...
Breaking Biology Technology:
Cached News: